CClinicalTrials.gg
Status unknownNCT03176108DP-KIDUpdated Jan 23, 2023

Evaluation of a Parent/Child Cognitive-Behaviorial Therapy Program in ADHD Children With Emotional Dysregulation Profile

An interventional study of Cognitive Behavorial Therapy (CBT) and Body mediation in Attention Deficit Disorder With Hyperactivity and Attention-Deficit-Disordered Children, sponsored by University Hospital, Montpellier. Status unknown at 1 site in France. Open to participants aged 7 Years to 13 Years. Per ClinicalTrials.gov, last updated 2023-01-23.

Sponsored by University Hospital, Montpellier · Not applicable, Interventional, and Supportive care

The sponsor has not verified this record recently (last verified Jan 2023), so the status shown — last known as Recruiting — may be out of date.
Phase
Not applicable
Study type
Interventional
Enrollment
92
Allocation
Randomized
Ages
7 Years to 13 Years
Sex
All
01

Study summary

Attention Deficit Disorder (ADD) with or without Hyperactivity/Impulsivity (ADHD) is a neurodevelopmental syndrome that has a lasting impact on the child's daily lifestyle and leads to functional impairment. ADHD is recognized as the most common psychiatry disorder in children and it's considered as a public health problem.

ADHD is frequently associated with a new diagnostic entity " Disruptive Disorder with Emotional dysregulation ". This disorder is characterized by crisis of anger with verbal or physical aggression, intensity disproportionate to the context and developmental age.

Few studies have examined the elements of emotional dysregulation in ADHD in children. Many studies have shown the interest of CBT in multimodal management of ADHD symptoms and associated disorders.

The main objective is to evaluate the effectiveness of a Cognitive-Behavioral Therapy Parent/Child program versus a body mediation focused on emotional and behaviorial aspects in ADD children aged 7-13 years with dimensional emotional dysregulation at 6 months after intervention. Secondary objectives are to evaluate the impact of this program, at short-term (at the end of CBT) and at 6 months after intervention, on socio-communicative capacities, quality of life, children's functioning and parental stress.

It's a biomedical research, prospective, controlled, randomized, monocentric, two parallels, with an evaluation of the criteria of blind judgment.

Read the detailed description

68 patients (parents and children) will be recruited within Montpellier University Hospital. They will be divided into a CBT group and a control group (body mediation).

The CBT group benefits from an intervention based on the program "Better manage its anger and its frustrations" of 15 sessions for the children.

The control group participates in an intervention of body mediation (theatre) of 15 session for the children.

The parents of CBT and Control groups participate in an CBT intervention of 8 sessions every 15 days.

02

Conditions studied

  • Attention Deficit Disorder With Hyperactivity
  • Attention-Deficit-Disordered Children
03

In context

Attention Deficit Disorder with Hyperactivity

1,514 studies on the registry are indexed under Attention Deficit Disorder with Hyperactivity; 255 are open to participants now.

This study's planned enrollment of 92 is above the median of 72 across 1,207 interventional studies indexed under Attention Deficit Disorder with Hyperactivity.

Browse Attention Deficit Disorder with Hyperactivity studies →

Lead sponsor

University Hospital, Montpellier is the lead sponsor of 1,244 studies on the registry; 225 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
7 Years to 13 Years
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Children and adolescents aged 7-13 years ;
  • Children with a diagnostic of ADHD (diagnostics criteria from DSM-V);
  • Score CBCL-DP ≥ 180 (" Aggressive behavior ", " Anxious-depression " and " Attention problems ") ;
  • Children follow-up in Montpellier University Hospital ;
  • Parents and children benefit of social security.

Exclusion criteria

Exclusion Criteria:

  • Children with a developmental delay or severe language disorder ;
  • Families non-french speaking ;
  • Absence of consent signed by parents and child ;
  • Children not living with at least one parent.
05

Study design

Phase
Not applicable
Primary purpose
Supportive care
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
92 participants (estimated)

Study arms

  • Experimental
    CBT Group

    The CBT group benefits of an intervention based on the program "Better manage its anger and its frustrations" of 15 sessions for the children. Parents participate in an CBT intervention of 8 sessions every 15 days. The session allow to develop adapted behaviors, to manage the disruptive behaviors and to improve the relations parents/children.

    Behavioral: Cognitive Behavorial Therapy (CBT)

  • Sham comparator
    Control Group

    The control group participates in an intervention of body mediation (theatre) of 15 session for the children. Parents participate in an CBT intervention of 8 sessions every 15 days. The session allow to develop adapted behaviors, to manage the disruptive behaviors and to improve the relations parents/children.

    Behavioral: Body mediation

Interventions

  • BehavioralCognitive Behavorial Therapy (CBT)

    Cognitive Behaviorial Therapy (CBT)

  • BehavioralBody mediation

    Body mediation (theatre)

06

What researchers measure

Primary outcomes

  1. Variation between the initial assessment and the month evaluation atfer the end of the intervention on the score of the " Aggressive behavior " subscale at the CBCL (Child Behavior Checklist)

    The Questionnaire is completed by parents

    Time frame: Evaluation at inclusion, 6 months and 12 months

Secondary outcomes

  1. :* Variation of total score on CBCL and score on " Dysregulation profile " (CBCL-DP) on Child Behavior Checklist

    The Questionnaire is completed by parents

    Time frame: Evaluation at inclusion, 6 months and 12 months

  2. Variation of scores on " Strengths and Difficulties Questionnaire "

    Description: The Questionnaire is completed by parents and teachers

    Time frame: Evaluation at inclusion, 6 months and 12 months

  3. Variation of scores on " Parenting Stress Index "

    The Questionnaire is completed by parents

    Time frame: Evaluation at inclusion, 6 months and 12 months

  4. Variation of score on " Beck Depression Inventory "

    The Questionnaire is completed by parents

    Time frame: Evaluation at inclusion, 6 months and 12 months

  5. Variation of scores on " Kidscreen-27 "

    The Questionnaire is completed by parents

    Time frame: Evaluation at inclusion, 6 months and 12 months

  6. Variation of score on " PAR-ENT-Qol "

    The Questionnaire is completed by parents

    Time frame: Evaluation at inclusion, 6 months and 12 months

  7. Variation of score on " Children's Global Assessment Scale " (C-GAS)

    The Questionnaire is completed by the evaluator who receive parents and their child.

    Time frame: Evaluation at inclusion, 6 months and 12 months

07

Study locations

1 of 1 sites recruiting
08

References and documents

Publications

  • Vacher C, Romo L, Dereure M, Soler M, Picot MC, Purper-Ouakil D. Efficacy of cognitive behavioral therapy on aggressive behavior in children with attention deficit hyperactivity disorder and emotion dysregulation: study protocol of a randomized controlled trial. Trials. 2022 Feb 7;23(1):124. doi: 10.1186/s13063-022-05996-5. PubMed 35130934 ↗

Individual participant data

Plan to share: No

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jan 23, 2023, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT03176108
Lead sponsor
University Hospital, Montpellier
Responsible party
Sponsor
First posted
Jun 5, 2017
Start date
Jun 28, 2017
Primary completion
Mar 28, 2024 (estimated)
Completion
Mar 28, 2025 (estimated)
Last update
Jan 23, 2023

Study contacts

Cecile VACHER, Psychologist
Contact
c-vacher@chu-montpellier.fr
+33.4.64.33.71.97
Elodie COURTABESSIS, MD PHD
principal investigator · University Hospital, Montpellier

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Jan 2023. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion